Anyone genuinely interested in this stock should go to the company website and read the Shareholder update of 22/12/20.
Ian Dixon has a deserved reputation as a straight shooter ,practical and commercial , who under promises with the intention of over delivering.
He lays out quite clearly what's in store for EX1 this year . This is what's happening on the ground in this company. Since Codiak listed and Governments worldwide are trying to fast track solutions to health problems the interest is accelerating. As is the interest of investors.
Codiak ($800mil market capitalisation), page-145
-
- There are more pages in this discussion • 39 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
-0.001(5.00%) |
Mkt cap ! $20.69M | |||
| Open | High | Low | Value | Volume |
| 2.0¢ | 2.0¢ | 1.9¢ | $18.75K | 951.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 183839 | 1.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.0¢ | 1000000 | 1 |
View Market Depth
| Last trade - 11.43am 11/10/2024 (20 minute delay) ? |
| TYP (ASX) Chart |